RUNX2 and breast cancer: This study reveals that RUNX2 expression in luminal BC cells is associated with several oncogenic features: lower levels of estrogen receptor-α (ERα), anchorage-independent growth, increased expression of glycolytic genes (such as LDHA, HK2, and GLUT1), heightened glucose uptake, and sensitivity to glucose starvation.